ANDERSON DANIEL GRIFFITH

Other

US·SEC (Form 4)

Sigilon Therapeutics, Inc.

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

€3m

▼ Sales (2 ops.)

Browse the full record of transactions filed by ANDERSON DANIEL GRIFFITH. Director active across 1 companies, notably Sigilon Therapeutics, Inc.. Aggregated, 2 reports have been published. Total volume traded: €3.3m. The latest transaction was disclosed on 2 June 2021 (Cession). Regulator: SEC (Form 4). All data is free.

Declarations2 total

Executives▼SaleSSigilon Therapeutics, Inc.17SEC

A

ANDERSON DANIEL GRIFFITHDirector

€2m200,000 shares@ €8.1901100.0% of flow

Common Stock

SEC:0001415889-21-002817·2 Jun 2021

SEC ↗

Executives▼SaleSSigilon Therapeutics, Inc.16SEC

A

ANDERSON DANIEL GRIFFITHDirector

€2m200,000 shares@ €8.190150.0% of flow